Selected research
Industry Research
Neomycin Industry Research Report 2026
Market perspective
The global Neomycin market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Neomycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Neomycin is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Neomycin is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Neomycin include Aba Chem Scene, Angene, Biosynth, DC Chemicals, MuseChem, Weibo, Yuanye Biology and Chem Strong, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Neomycin market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Neomycin Market by Company
Aba Chem Scene
Angene
Biosynth
DC Chemicals
MuseChem
Yuanye Biology
Chem Strong
Neomycin Segment by Type
98% Purity Type
95% Purity Type
Others
Neomycin Segment by Application
Neomycin Sulfate Eye Drops
Neomycin Sulfate Tablets
Compound Neomycin Ointment
Neomycin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Neomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neomycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Neomycin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Neomycin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Neomycin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 98% Purity Type
- 95% Purity Type
- Others
Applications
- Neomycin Sulfate Eye Drops
- Neomycin Sulfate Tablets
- Compound Neomycin Ointment
Companies covered
- Aba Chem Scene
- Angene
- Biosynth
- DC Chemicals
- MuseChem
- Yuanye Biology
- Chem Strong
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Neomycin Market Size (2021-2032)
- 2.2.2 Global Neomycin Sales (2021-2032)
- 2.2.3 Global Neomycin Market Average Price (2021-2032)
- 2.3 Neomycin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 98% Purity Type
- 2.3.3 95% Purity Type
- 2.3.4 Others
- 2.4 Neomycin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Neomycin Sulfate Eye Drops
- 2.4.3 Neomycin Sulfate Tablets
- 2.4.4 Compound Neomycin Ointment
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Neomycin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Neomycin Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Neomycin Revenue of Manufacturers (2021-2026)
- 3.4 Global Neomycin Average Price by Manufacturers (2021-2026)
- 3.5 Global Neomycin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Neomycin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Neomycin, Product Type & Application
- 3.8 Global Manufacturers of Neomycin, Established Date
- 3.9 Global Neomycin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aba Chem Scene
- 4.1.1 Aba Chem Scene Company Information
- 4.1.2 Aba Chem Scene Business Overview
- 4.1.3 Aba Chem Scene Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aba Chem Scene Neomycin Product Portfolio
- 4.1.5 Aba Chem Scene Recent Developments
- 4.2 Angene
- 4.2.1 Angene Company Information
- 4.2.2 Angene Business Overview
- 4.2.3 Angene Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Angene Neomycin Product Portfolio
- 4.2.5 Angene Recent Developments
- 4.3 Biosynth
- 4.3.1 Biosynth Company Information
- 4.3.2 Biosynth Business Overview
- 4.3.3 Biosynth Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Biosynth Neomycin Product Portfolio
- 4.3.5 Biosynth Recent Developments
- 4.4 DC Chemicals
- 4.4.1 DC Chemicals Company Information
- 4.4.2 DC Chemicals Business Overview
- 4.4.3 DC Chemicals Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 DC Chemicals Neomycin Product Portfolio
- 4.4.5 DC Chemicals Recent Developments
- 4.5 MuseChem
- 4.5.1 MuseChem Company Information
- 4.5.2 MuseChem Business Overview
- 4.5.3 MuseChem Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 MuseChem Neomycin Product Portfolio
- 4.5.5 MuseChem Recent Developments
- 4.6 Weibo
- 4.6.1 Weibo Company Information
- 4.6.2 Weibo Business Overview
- 4.6.3 Weibo Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Weibo Neomycin Product Portfolio
- 4.6.5 Weibo Recent Developments
- 4.7 Yuanye Biology
- 4.7.1 Yuanye Biology Company Information
- 4.7.2 Yuanye Biology Business Overview
- 4.7.3 Yuanye Biology Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yuanye Biology Neomycin Product Portfolio
- 4.7.5 Yuanye Biology Recent Developments
- 4.8 Chem Strong
- 4.8.1 Chem Strong Company Information
- 4.8.2 Chem Strong Business Overview
- 4.8.3 Chem Strong Neomycin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Chem Strong Neomycin Product Portfolio
- 4.8.5 Chem Strong Recent Developments
5 Global Neomycin Market Scenario by Region
- 5.1 Global Neomycin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Neomycin Sales by Region: 2021-2032
- 5.2.1 Global Neomycin Sales by Region: 2021-2026
- 5.2.2 Global Neomycin Sales by Region: 2027-2032
- 5.3 Global Neomycin Revenue by Region: 2021-2032
- 5.3.1 Global Neomycin Revenue by Region: 2021-2026
- 5.3.2 Global Neomycin Revenue by Region: 2027-2032
- 5.4 North America Neomycin Market Facts & Figures by Country
- 5.4.1 North America Neomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Neomycin Sales by Country (2021-2032)
- 5.4.3 North America Neomycin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Neomycin Market Facts & Figures by Country
- 5.5.1 Europe Neomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Neomycin Sales by Country (2021-2032)
- 5.5.3 Europe Neomycin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Neomycin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Neomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Neomycin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Neomycin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Neomycin Market Facts & Figures by Country
- 5.7.1 South America Neomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Neomycin Sales by Country (2021-2032)
- 5.7.3 South America Neomycin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Neomycin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Neomycin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Neomycin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Neomycin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Neomycin Sales by Type (2021-2032)
- 6.1.1 Global Neomycin Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Neomycin Sales Market Share by Type (2021-2032)
- 6.2 Global Neomycin Revenue by Type (2021-2032)
- 6.2.1 Global Neomycin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Neomycin Revenue Market Share by Type (2021-2032)
- 6.3 Global Neomycin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Neomycin Sales by Application (2021-2032)
- 7.1.1 Global Neomycin Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Neomycin Sales Market Share by Application (2021-2032)
- 7.2 Global Neomycin Revenue by Application (2021-2032)
- 7.2.1 Global Neomycin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Neomycin Revenue Market Share by Application (2021-2032)
- 7.3 Global Neomycin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Neomycin Value Chain Analysis
- 8.1.1 Neomycin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Neomycin Production Mode & Process
- 8.2 Neomycin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Neomycin Distributors
- 8.2.3 Neomycin Customers
9 Global Neomycin Analyzing Market Dynamics
- 9.1 Neomycin Industry Trends
- 9.2 Neomycin Industry Drivers
- 9.3 Neomycin Industry Opportunities and Challenges
- 9.4 Neomycin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst